Technology-supported Exercise Therapy for Patients With Chronic Low Back Pain

August 8, 2017 updated by: Annick Timmermans, Hasselt University

Technology-supported Exercise Therapy for Patients With Chronic Low Back Pain: Pilot Study

This clinical pilot trial will investigate the effects of technology-supported exercise therapy for chronic non-specific low back pain. Patients will follow an intensive rehabilitation program (2x/week for 18 weeks), with emphasis on motor control training that is supported by technology. The technological system consists out of motion tracking sensors that register the movements and position of the lumbar spine.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Anticipated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hasselt, Belgium, B3830
        • Universiteit Hasselt

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18-65 y.o.
  • Chronic non-specific low back pain, with or without leg pain
  • Motor control impairment
  • Sufficient knowledge of the Dutch language to understand instructions

Exclusion Criteria:

  • Spinal surgery in the past
  • Underlying serious pathologies (tumor, fracture, neurological diseases)
  • Signs or symptoms of nerve root compression
  • Pregnancy or less than 1 year post-partum
  • Known allergy for tape

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intensive rehabilitation program
Patients will follow an intensive rehabilitation program (2x/week for 18 weeks), with emphasis on motor control training that is supported by technology.
Patients will follow an intensive rehabilitation program (2x/week for 18 weeks), with emphasis on motor control training that is supported by technology. The technological system consists out of motion tracking sensors that register the movements and position of the lumbar spine.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The numeric pain rating scale
Time Frame: baseline
the numeric pain rating scale (0-10)
baseline
The numeric pain rating scale
Time Frame: week 3
the numeric pain rating scale (0-10)
week 3
The numeric pain rating scale
Time Frame: week 8
the numeric pain rating scale (0-10)months post-intervention.
week 8
The numeric pain rating scale
Time Frame: week 13
the numeric pain rating scale (0-10)
week 13
The numeric pain rating scale
Time Frame: week 18
the numeric pain rating scale (0-10)
week 18
The numeric pain rating scale
Time Frame: week 44
the numeric pain rating scale (0-10)
week 44
Roland Morris Questionnaire (0-24)
Time Frame: baseline
Roland Morris Questionnaire (0-24)
baseline
Roland Morris Questionnaire (0-24)
Time Frame: week 3
Roland Morris Questionnaire (0-24)
week 3
Roland Morris Questionnaire (0-24)
Time Frame: week 8
Roland Morris Questionnaire (0-24)
week 8
Roland Morris Questionnaire (0-24)
Time Frame: week 13
Roland Morris Questionnaire (0-24)
week 13
Roland Morris Questionnaire (0-24)
Time Frame: week 18
Roland Morris Questionnaire (0-24)
week 18
Roland Morris Questionnaire (0-24)
Time Frame: week 44
Roland Morris Questionnaire (0-24)
week 44
Patient specific functioning scale (0-10)
Time Frame: baseline
Patient specific functioning scale (0-10)
baseline
Patient specific functioning scale (0-10)
Time Frame: week 3
Patient specific functioning scale (0-10)
week 3
Patient specific functioning scale (0-10)
Time Frame: week 8
Patient specific functioning scale (0-10)
week 8
Patient specific functioning scale (0-10)
Time Frame: week 13
Patient specific functioning scale (0-10)
week 13
Patient specific functioning scale (0-10)
Time Frame: week 18
Patient specific functioning scale (0-10)
week 18
Patient specific functioning scale (0-10)
Time Frame: week 44
Patient specific functioning scale (0-10)
week 44
Pain self-efficacy questionnaire (0-60)
Time Frame: baseline
Pain self-efficacy questionnaire (0-60)
baseline
Pain self-efficacy questionnaire (0-60)
Time Frame: week 3
Pain self-efficacy questionnaire (0-60)
week 3
Pain self-efficacy questionnaire (0-60)
Time Frame: week 8
Pain self-efficacy questionnaire (0-60)
week 8
Pain self-efficacy questionnaire (0-60)
Time Frame: week 13
Pain self-efficacy questionnaire (0-60)
week 13
Pain self-efficacy questionnaire (0-60)
Time Frame: week 18
Pain self-efficacy questionnaire (0-60)
week 18
Pain self-efficacy questionnaire (0-60)
Time Frame: week 44
Pain self-efficacy questionnaire (0-60)
week 44
the Tampa scale for kinesiophobia (17-68)
Time Frame: baseline
the Tampa scale for kinesiophobia (17-68)
baseline
the Tampa scale for kinesiophobia (17-68)
Time Frame: week 3
the Tampa scale for kinesiophobia (17-68)
week 3
the Tampa scale for kinesiophobia (17-68)
Time Frame: week 8
the Tampa scale for kinesiophobia (17-68)
week 8
the Tampa scale for kinesiophobia (17-68)
Time Frame: week 13
the Tampa scale for kinesiophobia (17-68)
week 13
the Tampa scale for kinesiophobia (17-68)
Time Frame: week 18
the Tampa scale for kinesiophobia (17-68)
week 18
the Tampa scale for kinesiophobia (17-68)
Time Frame: week 44
the Tampa scale for kinesiophobia (17-68)
week 44
Patient satisfaction with treatment (0-10)
Time Frame: baseline
Patient satisfaction with treatment (0-10)
baseline
Patient satisfaction with treatment (0-10)
Time Frame: week 3
Patient satisfaction with treatment (0-10)
week 3
Patient satisfaction with treatment (0-10)
Time Frame: week 8
Patient satisfaction with treatment (0-10)
week 8
Patient satisfaction with treatment (0-10)
Time Frame: week 13
Patient satisfaction with treatment (0-10)
week 13
Patient satisfaction with treatment (0-10)
Time Frame: week 18
Patient satisfaction with treatment (0-10)
week 18
Patient satisfaction with treatment (0-10)
Time Frame: week 44
Patient satisfaction with treatment (0-10)
week 44

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
short form 36
Time Frame: baseline
Quality of life, SF-36 questionnaire
baseline
short form 36
Time Frame: week 3
Quality of life, SF-36 questionnaire
week 3
short form 36
Time Frame: week 8
Quality of life, SF-36 questionnaire
week 8
short form 36
Time Frame: week 13
Quality of life, SF-36 questionnaire
week 13
short form 36
Time Frame: week 18
Quality of life, SF-36 questionnaire
week 18
short form 36
Time Frame: week 44
Quality of life, SF-36 questionnaire
week 44
Credibility and expectancy questionnaire
Time Frame: baseline
Credibility and expectancy questionnaire
baseline
Credibility and expectancy questionnaire
Time Frame: week 3
Credibility and expectancy questionnaire
week 3
Credibility and expectancy questionnaire
Time Frame: week 8
Credibility and expectancy questionnaire
week 8
Credibility and expectancy questionnaire
Time Frame: week 13
Credibility and expectancy questionnaire
week 13
Credibility and expectancy questionnaire
Time Frame: week 18
Credibility and expectancy questionnaire
week 18
Credibility and expectancy questionnaire
Time Frame: week 44
Credibility and expectancy questionnaire
week 44
Intrinsic motivation inventory form
Time Frame: baseline
Intrinsic motivation inventory form
baseline
Intrinsic motivation inventory form
Time Frame: week 3
Intrinsic motivation inventory form
week 3
Intrinsic motivation inventory form
Time Frame: week 8
Intrinsic motivation inventory form
week 8
Intrinsic motivation inventory form
Time Frame: week 13
Intrinsic motivation inventory form
week 13
Intrinsic motivation inventory form
Time Frame: week 18
Intrinsic motivation inventory form
week 18
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Time Frame: baseline
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
baseline
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Time Frame: week 3
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
week 3
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Time Frame: week 8
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
week 8
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Time Frame: week 13
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
week 13
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Time Frame: week 18
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
week 18
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
Time Frame: week 44
Work absenteeism because of LBP (low back pain) (yes (% of absenteeism), no)
week 44
Adherence to exercise program assessed by number of visits attended and self-reported adherence to home exercises
Time Frame: baseline
Adherence to exercise program (number of visits attended, self-reported adherence to home exercises)
baseline
Adherence to exercise program assessed by number of visits attended and self-reported adherence to home exercises
Time Frame: week 3
Adherence to exercise program (number of visits attended, self-reported adherence to home exercises)
week 3
Adherence to exercise program assessed by number of visits attended and self-reported adherence to home exercises
Time Frame: week 8
Adherence to exercise program (number of visits attended, self-reported adherence to home exercises)
week 8
Adherence to exercise program assessed by number of visits attended and self-reported adherence to home exercises
Time Frame: week 13
Adherence to exercise program (number of visits attended, self-reported adherence to home exercises)
week 13
Adherence to exercise program assessed by number of visits attended and self-reported adherence to home exercises
Time Frame: week18
Adherence to exercise program (number of visits attended, self-reported adherence to home exercises)
week18

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Thomas Matheve, drs., Hasselt University
  • Principal Investigator: annick Timmermans, prof.dr., Hasselt University
  • Study Chair: Guido Claes, MD, Jessa Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2013

Primary Completion (Actual)

March 1, 2015

Study Completion (Actual)

August 1, 2015

Study Registration Dates

First Submitted

December 13, 2014

First Submitted That Met QC Criteria

March 12, 2015

First Posted (Estimate)

March 13, 2015

Study Record Updates

Last Update Posted (Actual)

August 9, 2017

Last Update Submitted That Met QC Criteria

August 8, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PILOT2013TM01

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Non-specific Low Back Pain

Clinical Trials on intensive rehabilitation program

Subscribe